Freenome Holdings, Inc.
Blood-based cancer detection tests using circulating tumor DNA and protein biomarkers
New patent ·
- Sector
- Medtech
- Headquarters
- SOUTH SAN FRANCISCO, CA
- Founded
- 2016
- Latest Form D
- $243M, Dec 2021
- Total capital
- $743M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $743M
- 5 Form D · last Dec 2021
- 59 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 14
- 26 pending · first 2022
- Rank in peer group#13 of 160
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 5th filing$243M
- Private capital raisedForm D · SEC · 4th filing$270M
- Private capital raisedForm D · SEC · 3rd filing$160M
- Private capital raisedForm D · SEC · 2nd filing$63.9M
- Private capital raisedForm D · SEC · 1st filing$5.6M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 160 peers
Line = medianMedtech · Instrument
- Granted patents#13 · top 8%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Amir NashatDirectorNamed in SEC Form D filings
- Charles RobertsDirectorNamed in SEC Form D filings
- Ellen HukkelhovenDirectorNamed in SEC Form D filings
- Gabriel OtteExecutive Officer, Director, PromoterNamed in SEC Form D filings
- Michael NolanExecutive Officer, DirectorNamed in SEC Form D filings
- Peter KolchinskyDirectorNamed in SEC Form D filings
Show all 9 people
- Randal ScottDirectorNamed in SEC Form D filings
- Riley EnnisExecutive Officer, DirectorNamed in SEC Form D filings
- Vijay PandeDirectorNamed in SEC Form D filings
What it has protected
USPTO · 14 granted of 40- New patentMethods And Systems For Detecting Cancer Via Nucleic Acid Methylation AnalysisUSPTOUS 12,763,168
- GrantedAntibody Assay For The Detection And Treatment Of Liver CancerUSPTOUS 12,716,896
- GrantedTranscription Factor ProfilingUSPTOUS 12,682,984
Show all 40 patent records
- Methods And Systems For Detecting Cancer Via Nucleic Acid Methylation AnalysisOct 13, 2026 · US 12,763,168Granted
- Antibody Assay For The Detection And Treatment Of Liver CancerAug 25, 2026 · US 12,716,896Granted
- Transcription Factor ProfilingJul 14, 2026 · US 12,682,984Granted
- Analyte Binding Compositions, Methods, And SystemsJun 18, 2026 · Application 19382996Pending
- Methods And Systems For High-depth Sequencing Of Methylated Nucleic AcidMar 26, 2026 · Application 19346970Pending
- Methods And Systems For Detecting Colorectal Cancer Via Nucleic Acid Methylation AnalysisJan 29, 2026 · Application 19294628Pending
- Methods And Systems For High-depth Sequencing Of Methylated Nucleic AcidDec 23, 2025 · US 12,503,728Granted
- Markers For The Early Detection Of Colon Cell Proliferative DisordersDec 4, 2025 · Application 19240469Pending
- Methods And Systems For High-depth Sequencing Of Methylated Nucleic AcidOct 28, 2025 · US 12,454,724Granted
- Methods And Systems For Inferring Gene Expression Using Cell-free Dna FragmentsOct 2, 2025 · Application 19092296Pending
- Methods And Systems For Detecting Colorectal Cancer Via Nucleic Acid Methylation AnalysisSep 9, 2025 · US 12,410,480Granted
- Markers For The Early Detection Of Colon Cell Proliferative DisordersJul 29, 2025 · US 12,372,528Granted
- Markers For The Early Detection Of Colon Cell Proliferative DisordersJul 10, 2025 · Application 19018548Pending
- Markers For The Early Detection Of Colon Cell Proliferative DisordersMay 22, 2025 · Application 18962113Pending
- Generating Machine Learning Models Using Genetic DataMay 15, 2025 · Application 19022393Pending
- Tcr/bcr Profiling For Cell-free Nucleic Acid Detection Of CancerMay 8, 2025 · Application 18892913Pending
- Sequence Process Validation Methods And CompositionsApr 17, 2025 · Application 18975552Pending
- Methods And Compositions Of Nucleic Acid Molecule Enrichment For SequencingApr 17, 2025 · Application 18975556Pending
- Methods And Systems For Sample ExtractionMar 11, 2025 · US 12,247,905Granted
- Generating Machine Learning Models Using Genetic DataMar 4, 2025 · US 12,242,943Granted
- Markers For The Early Detection Of Colon Cell Proliferative DisordersFeb 18, 2025 · US 12,228,574Granted
- Diagnostic Data Feedback Loop And Methods Of Use ThereofAug 29, 2024 · Application 18533328Pending
- Compositions And Methods For Improved 5-HYDROXYMETHYLATED Cytosine Resolution In Nucleic Acid SequencingJul 18, 2024 · Application 18417054Pending
- Machine Learning Implementation For Multi-analyte Assay Development And TestingJun 20, 2024 · Application 18518274Pending
- Methods And Systems For Detecting Cancer Via Nucleic Acid Methylation AnalysisMar 14, 2024 · Application 18472529Pending
- Machine Learning Implementation For Multi-analyte Assay Development And TestingDec 19, 2023 · US 11,847,532Granted
- Methods And Systems For Sample ExtractionOct 10, 2023 · US 11,781,959Granted
- Machine Learning Implementation For Multi-analyte Assay Development And TestingJun 20, 2023 · US 11,681,953Granted
- Methods And Systems For Abnormality Detection In The Patterns Of Nucleic AcidsJun 8, 2023 · Application 18163106Pending
- Methods And Systems For Detecting Cancer Via Nucleic Acid Methylation AnalysisJun 8, 2023 · Application 18163174Pending
- Rna Markers And Methods For Identifying Colon Cell Proliferative DisordersMay 25, 2023 · Application 18049785Pending
- Methods And Systems For Detecting Colorectal Cancer Via Nucleic Acid Methylation AnalysisMar 30, 2023 · Application 17954576Pending
- Generating Machine Learning Models Using Genetic DataNov 29, 2022 · US 11,514,289Granted
- Methods And Systems For Analyzing MicrobiotaFeb 25, 2021 · Application 17035278Pending
- Methods And Systems For Abnormality Detection In The Patterns Of Nucleic AcidsJan 14, 2021 · Application 16937287Pending
- Fragment-level Deep Learning Model (fldl) For Cancer ClassificationApplication 63756398Pending
- Fragment-level Deep Learning Model (fldl) For Cancer ClassificationApplication 63964820Pending
- Analyte Binding Compositions, Methods, And SystemsApplication 63717700Pending
- Fragment-level Deep Learning Model (fldl) For Cancer ClassificationApplication 63970223Pending
- Fragment-level Deep Learning Model (fldl) For Cancer ClassificationApplication PCTUS2026014755Pending
Related companies, and why
- LEUKO LABS, INC.Similar federal contract value in Medtech · null in contracts
- BIOSYNESIS, INC.Similar federal contract value in Medtech · null in contracts
- MAY & MEADOW, INC.Similar federal contract value in Medtech · null in contracts
- PRO THERAPEUTICS LLCSimilar federal contract value in Medtech · null in contracts
- MedHab, LLCSimilar federal contract value in Medtech · null in contracts
- Extra Life Studios, LLCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .